Phenotypic characterization of CD8+ TILs from colorectal and lung cancer patients has revealed that CD39, rather than PD-1, could accurately distinguish between tumor-specific (CD39+) and cancer-unrelated T cells (CD39−) (117). The gene discussed is ENTPD1; the disease is lung cancer.